Key facts
- Notable investors include Quzhou State-owned Assets Supervision and Administration Commission Information Security Management, CBC Group (Singapore), Huagai Capital, Sinopharm Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Leiiio Peak
- ·The full record, as it builds
Funding rounds
No funding rounds for Leiiio Peak are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Leiiio Peak
Provider of life science laboratory automation equipment service designed for pipetting techniques. The company offers life science, pharmaceutical research and automated systems research related laboratory automation equipment, thereby enabling it to meet the growing automation needs of customers in China.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2022
- Employees
- 47
- Website
- labautobio.com/
- Ownership
- Privately Held (backing)
Leiiio Peak doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Leiiio Peak shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Leiiio Peak in its N-PORT filings yet. We sweep new filings monthly.